Ryota Shizu

604 total citations
47 papers, 470 citations indexed

About

Ryota Shizu is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Ryota Shizu has authored 47 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Pharmacology and 12 papers in Genetics. Recurrent topics in Ryota Shizu's work include Pharmacogenetics and Drug Metabolism (12 papers), Estrogen and related hormone effects (11 papers) and Hormonal Regulation and Hypertension (7 papers). Ryota Shizu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Estrogen and related hormone effects (11 papers) and Hormonal Regulation and Hypertension (7 papers). Ryota Shizu collaborates with scholars based in Japan, United States and South Korea. Ryota Shizu's co-authors include Kouichi Yoshinari, Takuomi Hosaka, Takamitsu Sasaki, Susumu Kodama, Masahiko Negishi, Taiki Abe, Takemi Yoshida, Satoshi Numazawa, L. Perera and Atsushi Matsuzawa and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Ryota Shizu

39 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryota Shizu Japan 14 217 183 99 91 86 47 470
Yoav Timsit United States 11 198 0.9× 268 1.5× 127 1.3× 158 1.7× 115 1.3× 15 581
Makoto Osabe Japan 11 183 0.8× 204 1.1× 156 1.6× 84 0.9× 99 1.2× 15 480
Delira Robbins United States 14 277 1.3× 101 0.6× 61 0.6× 112 1.2× 57 0.7× 19 532
Caitlin Lynch United States 14 154 0.7× 171 0.9× 88 0.9× 91 1.0× 94 1.1× 26 464
Michele Campaigne Larsen United States 16 283 1.3× 196 1.1× 46 0.5× 105 1.2× 107 1.2× 30 697
Saki Gotoh Japan 12 261 1.2× 88 0.5× 71 0.7× 50 0.5× 40 0.5× 18 429
Anja Rode United Kingdom 14 303 1.4× 362 2.0× 103 1.0× 239 2.6× 149 1.7× 15 758
Irina Grabovec Belarus 8 200 0.9× 169 0.9× 107 1.1× 55 0.6× 50 0.6× 17 409
Timothy Moeller United States 9 134 0.6× 161 0.9× 91 0.9× 69 0.8× 58 0.7× 10 356
Benjamin A. Kandel Germany 7 145 0.7× 158 0.9× 54 0.5× 113 1.2× 33 0.4× 8 353

Countries citing papers authored by Ryota Shizu

Since Specialization
Citations

This map shows the geographic impact of Ryota Shizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Shizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Shizu more than expected).

Fields of papers citing papers by Ryota Shizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Shizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Shizu. The network helps show where Ryota Shizu may publish in the future.

Co-authorship network of co-authors of Ryota Shizu

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Shizu. A scholar is included among the top collaborators of Ryota Shizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Shizu. Ryota Shizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kubota, Atsuhito, Atsuko Araki, Koji Nakagawa, et al.. (2025). Comparative study on gene expression profiles in the liver of male neonatal mice prenatally exposed to PFOA and its alternative HFPO-DA. Toxicology. 511. 154048–154048. 1 indexed citations
4.
Sato, Takumi, et al.. (2024). Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expression. Biochemical Journal. 481(18). 1173–1186. 2 indexed citations
5.
Watanabe, Naoya, Yukiko Kaneko, Hisamitsu Ishihara, et al.. (2024). Diacylglycerol kinase ζ is a positive insulin secretion regulator in pancreatic β-cell line MIN6. Biochemical and Biophysical Research Communications. 742. 151109–151109.
6.
Sasaki, Takamitsu, et al.. (2024). Utility of human cytochrome P450 inhibition data in the assessment of drug-induced liver injury. Xenobiotica. 54(7). 411–419. 2 indexed citations
7.
Watanabe, Miwa, et al.. (2023). Screening for DAX1/EWS‐FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma. Cancer Medicine. 12(8). 9802–9814. 4 indexed citations
8.
Sato, Takumi, Ryota Shizu, Yoshie Miura, et al.. (2022). Development of a strategy to identify and evaluate direct and indirect activators of constitutive androstane receptor in rats. Food and Chemical Toxicology. 170. 113510–113510. 2 indexed citations
9.
Kanno, Yuichiro, Nao Saito, Ryota Saito, et al.. (2022). Differential DNA-binding and cofactor recruitment are possible determinants of the synthetic steroid YK11-dependent gene expression by androgen receptor in breast cancer MDA-MB 453 cells. Experimental Cell Research. 419(2). 113333–113333. 2 indexed citations
10.
Lee, Su‐Jun, Ryota Shizu, & Masahiko Negishi. (2021). Glucocorticoid receptor dimerization in the cytoplasm might be essential for nuclear localization. Biochemical and Biophysical Research Communications. 553. 154–159. 9 indexed citations
11.
12.
Shimizu, Yuki, et al.. (2021). Association of CYP1A1 and CYP1B1 inhibition in <i>in vitro</i> assays with drug-induced liver injury. The Journal of Toxicological Sciences. 46(4). 167–176. 14 indexed citations
13.
Shizu, Ryota, et al.. (2020). A7 - Interaction with yap is a possible underlying mechanism for car-dependent hepatocarcinogenesis. Drug Metabolism and Pharmacokinetics. 35(1). S20–S20. 1 indexed citations
15.
Shizu, Ryota & Kouichi Yoshinari. (2020). Nuclear receptor CAR-mediated liver cancer and its species differences. Expert Opinion on Drug Metabolism & Toxicology. 16(4). 343–351. 21 indexed citations
16.
Hosaka, Takuomi, et al.. (2020). Construction of a PPARα Reporter Assay System with Drug-Metabolizing Capability. 3(1). 7–10. 1 indexed citations
18.
Abe, Taiki, Ryota Shizu, Takamitsu Sasaki, et al.. (2019). Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism. Journal of Pharmacology and Experimental Therapeutics. 371(3). 590–601. 14 indexed citations
19.
Sasaki, Takamitsu, Yuki Shimizu, Hitomi Oki, et al.. (2019). Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity. Toxicology and Applied Pharmacology. 388. 114854–114854. 7 indexed citations
20.
Shizu, Ryota, et al.. (2012). MicroRNA-122 Down-Regulation Is Involved in Phenobarbital-Mediated Activation of the Constitutive Androstane Receptor. PLoS ONE. 7(7). e41291–e41291. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026